Literature DB >> 24627346

Inappropriate utilization of SPECT myocardial perfusion imaging on the USA-Mexico border.

Omosalewa O Lalude1, Mell F Gutarra, Eduardo N Pollono, Soyoung Lee, Patrick M Tarwater.   

Abstract

BACKGROUND: The American College of Cardiology/American Society of Nuclear Cardiology published revised appropriate use criteria (AUC) for SPECT MPI in 2009. We assessed adherence to these guidelines and factors associated with inappropriate utilization at the University Medical Center.
METHODS: The AUC was applied retrospectively to 420 SPECT MPI studies. Two-sample t test, Fisher's exact test, and multivariable logistic regression models were used for analysis.
RESULTS: There were 322 appropriate (86%) and 54 (14%) inappropriate studies. The odds of having an inappropriate test increased with younger age (P < .001) and female gender (P < .001). Subjects with diabetes (P = .007) and chest pain (P < .001) were less likely to have an inappropriate test. Academic outpatients were three times more likely to have an inappropriate study (P = .123), while community PCPs were 5.6 times (P = .011) and community cardiologists eight times more likely to order inappropriate tests (P = .031).
CONCLUSIONS: Inappropriate SPECT MPI in low risk younger women is an important issue on the USA-Mexico border. Initiatives to reduce inappropriate SPECT MPI should focus on a few indications and evaluation of cardiovascular symptoms in younger age women in outpatient/community practices.

Entities:  

Mesh:

Year:  2014        PMID: 24627346     DOI: 10.1007/s12350-014-9881-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  15 in total

1.  Gender disparity and the appropriateness of myocardial perfusion imaging.

Authors:  Aarti Gupta; Sarah V Tsiaras; Shira I Dunsiger; Peter L Tilkemeier
Journal:  J Nucl Cardiol       Date:  2011-04-23       Impact factor: 5.952

2.  The impact of ordering provider specialty on appropriateness classification.

Authors:  Damita Jo Carryer; J Wells Askew; David Hodge; Todd D Miller; Raymond J Gibbons
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

Review 3.  ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association.

Authors:  Ralph G Brindis; Pamela S Douglas; Robert C Hendel; Eric D Peterson; Michael J Wolk; Joseph M Allen; Manesh R Patel; Ira E Raskin; Robert C Hendel; Timothy M Bateman; Manuel D Cerqueira; Raymond J Gibbons; Linda D Gillam; John A Gillespie; Robert C Hendel; Ami E Iskandrian; Scott D Jerome; Harlan M Krumholz; Joseph V Messer; John A Spertus; Stephen A Stowers
Journal:  J Am Coll Cardiol       Date:  2005-10-18       Impact factor: 24.094

Review 4.  The new era of medical imaging--progress and pitfalls.

Authors:  John K Iglehart
Journal:  N Engl J Med       Date:  2006-06-29       Impact factor: 91.245

5.  ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine.

Authors:  Robert C Hendel; Daniel S Berman; Marcelo F Di Carli; Paul A Heidenreich; Robert E Henkin; Patricia A Pellikka; Gerald M Pohost; Kim A Williams
Journal:  J Am Coll Cardiol       Date:  2009-06-09       Impact factor: 24.094

6.  Health insurers and medical-imaging policy--a work in progress.

Authors:  John K Iglehart
Journal:  N Engl J Med       Date:  2009-03-05       Impact factor: 91.245

7.  Impact of an automated multimodality point-of-order decision support tool on rates of appropriate testing and clinical decision making for individuals with suspected coronary artery disease: a prospective multicenter study.

Authors:  Fay Y Lin; Allison M Dunning; Jagat Narula; Leslee J Shaw; Heidi Gransar; Daniel S Berman; James K Min
Journal:  J Am Coll Cardiol       Date:  2013-05-22       Impact factor: 24.094

8.  Application of appropriateness criteria to stress single-photon emission computed tomography sestamibi studies and stress echocardiograms in an academic medical center.

Authors:  Raymond J Gibbons; Todd D Miller; David Hodge; Lynn Urban; Philip A Araoz; Patricia Pellikka; Robert B McCully
Journal:  J Am Coll Cardiol       Date:  2008-04-01       Impact factor: 24.094

9.  Appropriate use criteria for stress single-photon emission computed tomography sestamibi studies: a quality improvement project.

Authors:  Raymond J Gibbons; J Wells Askew; David Hodge; Beth Kaping; Damita J Carryer; Todd Miller
Journal:  Circulation       Date:  2011-01-24       Impact factor: 29.690

10.  The use of a learning community and online evaluation of utilization for SPECT myocardial perfusion imaging.

Authors:  Samira Saifi; Allen J Taylor; Joseph Allen; Robert Hendel
Journal:  JACC Cardiovasc Imaging       Date:  2013-05-01
View more
  3 in total

1.  The value and appropriateness of positron emission tomography: an evolving tale.

Authors:  Robert C Hendel
Journal:  J Nucl Cardiol       Date:  2014-08-23       Impact factor: 5.952

Review 2.  Outcomes after inappropriate nuclear myocardial perfusion imaging: A meta-analysis.

Authors:  Islam Y Elgendy; Ahmed Mahmoud; Jonathan J Shuster; Rami Doukky; David E Winchester
Journal:  J Nucl Cardiol       Date:  2015-08-08       Impact factor: 5.952

Review 3.  Appropriate Use of Cardiac Stress Testing with Imaging: A Systematic Review and Meta-Analysis.

Authors:  Joseph A Ladapo; Saul Blecker; Michael O'Donnell; Saahil A Jumkhawala; Pamela S Douglas
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.